| Particulars |
| Company Name |
Concord Biotech Ltd |
| Face Value |
1 |
| BSE Code |
543960 |
| Year End |
202603 |
| Full Year |
| Equity (Rs . Cr) |
20.92 |
| B.V. (Rs) |
99.70 |
| Sales (Rs . Cr) |
1,055.07 |
| NP (Rs . Cr) |
249.88 |
| NP Var% |
-30.00 |
| Div% |
755.00 |
| CPS (Rs) |
15.50 |
| EPS (Rs) |
11.90 |
| Traded Value(Rs . Lakhs) |
169.72 |
| 52 Week High |
807.00 |
| 52 Week Low |
494.00 |
| Price BSE |
561.00 |
| Price NSE |
561.00 |
| Market Capital(Rs . Cr) |
11,738.98 |
| P/C Ratio |
36.20 |
| P/E Ratio |
47.00 |
| Price Vs.BV |
5.63 |
| Latest Quarter |
| Year End |
202609 |
| Sales (Rs . Cr) |
312.31 |
| NP (Rs . Cr) |
75.71 |
| NP Var % |
20.00 |
| Trailing Twelve Months |
| Year End |
202609 |
| Sales |
1,085.75 |
| OPM |
42.50 |
| NP |
328.71 |
| NP Var% |
-7.56 |
| EPS |
14.20 |
| PE |
39.51 |
|